Emergency Medicine
Episodes 17-32 of 63
- MinuteCE®
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
1.75 program credits
Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
Bruce L. Davidson, MD, MPH
Alfonso J. Tafur, MD, MS, MBA, RPVI
- MinuteCE®
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
1.75 program creditsScott Kaatz, DO, MSc, FACP, SFHM
Sagar Lonial, MD, FACP
Caitlin Costello, MD
- MinuteCE®
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
1.00 program creditSagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Caitlin Costello, MD
- MinuteCE®
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
1.00 program creditSagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Caitlin Costello, MD
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Rhonda Cadena, MD, FNCS, FCCM
